Metformin and statins reduce hepatocellular carcinoma risk in chronic hepatitis C patients with failed antiviral therapy

Pei-Chien TsaiChung-Feng HuangMing-Lun YehMeng-Hsuan HsiehJIA-HORNG KAOCHUN-JEN LIUet al.2024-11-272024-11-272024-07-0122872728https://scholars.lib.ntu.edu.tw/handle/123456789/723307true[SDGs]SDG3Metformin and statins reduce hepatocellular carcinoma risk in chronic hepatitis C patients with failed antiviral therapyjournal article2-s2.0-85200944394